Cancer

The presentation of Cushing’s disease varies by age, with older adults having fewer hallmark features of the condition and more comorbidities, according to study findings published in The Journal of Clinical Endocrinology & Metabolism.

Iron deficiency may be linked to non-dialysis-dependent chronic kidney disease and mortality in patients without anemia, according to results of a nationwide cohort study.

Individuals with vitiligo did not display a significantly increased risk for cancer compared with the general population, according to a study.

Teens with cancer who participated in family-centered advance care planning reported greater levels of pain, depression and anxiety after 12 months, according to results published in Pediatrics.

Targeted therapies for active inflammatory arthritis should be started “without delay” for patients with cancer in remission, according to new EULAR points to consider published in Annals of the Rheumatic Diseases.

The FDA announced it has authorized the marketing of 20 Zyn nicotine pouch products, citing their greater health benefits vs. cigarettes and other tobacco products.

A novel topical gel, HT-001, has shown potential as a treatment for cutaneous side effects from epidermal growth factor receptor inhibitor cancer therapy, according to a Hoth Therapeutics press release detailing phase 2a interim data.

One in eight women will suffer from breast cancer in their lifetime. Eight percent will decline treatment due to the fear of alopecia.

In a nonoccupational setting, low ambient benzene exposure over a year was linked to a heightened mortality risk, according to results published in American Journal of Respiratory and Critical Care Medicine.

As the year comes to a close, Healio Dermatology has assembled this year’s most-read cutaneous oncology articles.